Expert Review of Pharmacoeconomics and Outcomes Research

Use of economic models in formulary decisions
pp. 295-298(4)
Author: Summers, Kent H

News in Brief
pp. 299-305(7)

Method without madness
pp. 305-307(3)
Author: Drummond, Michael

Change and stability in the Canadian healthcare system
pp. 309-312(4)
Authors: Brown, Murray G; Hicks, Vern; Tett, Susan

Indirect medical costs in the first 3 years of rheumatoid arthritis: comparison of current methodological approaches
pp. 313-318(6)
Authors: Merkesdal, Sonja; Ruof, Jörg; Mittendorf, Thomas; Zeidler, Henning; Mau, Wilfried

Discrete choice experiments to measure consumer preferences for health and healthcare
pp. 319-326(8)
Authors: Viney, Rosalie; Lancsar, Emily; Louviere, Jordan

Economic impact of poor compliance with pharmaceuticals
pp. 327-335(9)
Author: Hughes, Dyfrig A

Update on the use of osteoarthritis-specific outcome measures
pp. 337-346(10)
Authors: Walters, Stephen J; Lloyd-Jones, Myfanwy

Impact of antipsychotic agents and their side effects on the quality of life in schizophrenia
pp. 347-356(10)
Authors: Ritsner, Michael; Kurs, Rena

Health-related quality of life issues in urinary urge incontinence
pp. 357-365(9)
Authors: Badía, Xavier; Ibarz, Raquel

Meta-analysis of rare and adverse event data
pp. 367-379(13)
Authors: Sutton, Alexander J; Cooper, Nicola J; Lambert, Paul C; Jones, David R; Abrams, Keith R; Sweeting, Michael J

Evaluation criteria for pharmacoeconomic and health economic Internet resources
pp. 381-388(8)
Author: McGhan, William F

Pharmacy benefit design options available to employers
pp. 389-396(8)
Author: Encinosa, William E